To sign up for our newsletter or print publications, please enter your contact information below.
Laura C. Michaelis, MD
Richard Parker, MD, provides an overview of this condition, which is common on patients with carcinoid syndrome.Â
Sunil Verma, MD, MSEd, FRCPC discusses new classes of therapies for HR+ Breast Cancer.
Two-pronged attack on chemotherapy-resistant leukemia cells
An Early Look at Research From the 2016 ASCO Annual Meeting
Drug against breast cancer is also highly potent against a frequent form of leukaemia
Improving natural killer cancer therapy: Study